Showing results (711-720 of 931) with videos related to

Sort By:
Pageof 94
Oncotarget|April 16, 2016
Sequential intensified conditioning followed by prophylactic DLI could reduce relapse of refractory acute leukemia after allo-HSCTLi Xuan, Zhiping Fan, Yu Zhang, et al.
Science Advances|December 5, 2025
Scalable metal-organic framework membranes through nonclassical crystallization for molecular separationDongchen Shi, Fen Huang, Kai Xue, et al.
International Journal of Behavioral Medicine|March 4, 2025
The Role of Social Support and Depressive Symptoms in Mediating the Association Between Hearing Loss and Self-neglect Among Older Adults in ChinaTeng-Fei Li, Guo-Qing Jiang, Ye-Ke He, et al.
Bone Marrow Transplantation|April 7, 2021
Metagenomic next-generation sequencing for identifying pathogens in central nervous system complications after allogeneic hematopoietic stem cell transplantationWenjun Liu, Zhiping Fan, Yan Zhang, et al.
Leukemia|December 14, 2019
Haploidentical transplantation might have superior graft-versus-leukemia effect than HLA-matched sibling transplantation for high-risk acute myeloid leukemia in first complete remission: a prospective multicentre cohort studySijian Yu, Fen Huang, Yu Wang, et al.
Transplantation|July 12, 2013
Spectrum of Epstein-Barr virus-associated diseases in recipients of allogeneic hematopoietic stem cell transplantationLi Xuan, Xinmiao Jiang, Jing Sun, et al.
Biosensors & Bioelectronics|May 26, 2022
Evaluation of chemotherapeutic response in living cells using subcellular Organelle‒Selective amphipathic carbon dotsRen-Siang Wu, Yu-Syuan Lin, Amit Nain, et al.
Plos One|September 19, 2019
Hematological and biochemical parameters for Chinese rhesus macaqueWenhai Yu, Xianhui Hao, Fengmei Yang, et al.
Oncotarget|November 29, 2016
Cholesterol import and steroidogenesis are biosignatures for gastric cancer patient survivalWei-Chun Chang, Shang-Fen Huang, Yang-Ming Lee, et al.
Zhonghua Xue Ye Xue Za Zhi = Zhonghua Xueyexue Zazhi|June 27, 2012
[The outcome and safety of mesenchymal stem cells from bone marrow of a third party donor in treatment of secondary poor graft function following allogeneic hematopoietic stem cell transplantation]Xiao-Dan Liu, Zhi-Ping Fan, Yan-Wen Peng, et al.
Pageof 94